Equities analysts predict that Equifax Inc. (NYSE:EFX) will post sales of $824.58 million for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Equifax’s earnings. The highest sales estimate is $825.88 million and the lowest is $822.6 million. Equifax posted sales of $728.3 million in the same quarter last year, which suggests a positive year-over-year growth rate of 13.2%. The firm is scheduled to announce its next earnings results after the market closes on Wednesday, April 26th.
According to Zacks, analysts expect that Equifax will report full year sales of $824.58 million for the current year, with estimates ranging from $3.35 billion to $3.42 billion. For the next year, analysts anticipate that the company will post sales of $3.65 billion per share, with estimates ranging from $3.59 billion to $3.7 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that that provide coverage for Equifax.
Equifax (NYSE:EFX) last announced its quarterly earnings data on Wednesday, February 8th. The company reported $1.42 EPS for the quarter, beating the Zacks’ consensus estimate of $1.38 by $0.04. The business earned $801.10 million during the quarter, compared to the consensus estimate of $799.53 million. Equifax had a return on equity of 25.18% and a net margin of 15.54%. The business’s revenue for the quarter was up 20.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.14 earnings per share.
A number of equities research analysts have weighed in on EFX shares. Royal Bank of Canada restated an “outperform” rating on shares of Equifax in a research report on Wednesday, February 15th. Morgan Stanley downgraded Equifax from an “overweight” rating to an “equal weight” rating and set a $137.00 target price for the company. in a research report on Wednesday, January 18th. Zacks Investment Research upgraded Equifax from a “sell” rating to a “hold” rating in a research report on Tuesday, February 14th. Goldman Sachs Group Inc downgraded Equifax from a “neutral” rating to a “sell” rating and upped their target price for the stock from $100.00 to $116.00 in a research report on Friday, January 20th. Finally, Stifel Nicolaus upped their target price on Equifax from $131.00 to $144.00 and gave the stock a “buy” rating in a research report on Friday, February 10th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $139.27.
Shares of Equifax (NYSE:EFX) traded up 0.14% during midday trading on Thursday, hitting $135.50. The stock had a trading volume of 106,740 shares. The company’s 50-day moving average price is $134.17 and its 200-day moving average price is $125.66. Equifax has a 12-month low of $110.87 and a 12-month high of $137.94. The firm has a market cap of $16.24 billion, a price-to-earnings ratio of 33.54 and a beta of 0.83.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 15th. Stockholders of record on Friday, March 3rd were given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date was Wednesday, March 1st. This is an increase from Equifax’s previous quarterly dividend of $0.33. Equifax’s dividend payout ratio is 32.75%.
Large investors have recently made changes to their positions in the stock. The Manufacturers Life Insurance Company bought a new stake in shares of Equifax during the third quarter worth approximately $146,412,000. Norges Bank bought a new stake in shares of Equifax during the fourth quarter worth approximately $96,785,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new stake in shares of Equifax during the fourth quarter worth approximately $53,131,000. Congress Asset Management Co. MA bought a new stake in shares of Equifax during the fourth quarter worth approximately $52,432,000. Finally, BlackRock Institutional Trust Company N.A. increased its stake in shares of Equifax by 9.7% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 3,653,137 shares of the company’s stock worth $491,639,000 after buying an additional 323,834 shares during the period. Institutional investors own 86.41% of the company’s stock.
Equifax Inc is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates in four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Global Consumer Solutions. Its products and services are based on databases of consumer and business information derived from various sources, including credit, financial assets, telecommunications and utility payments, employment, income, demographic and marketing data.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/analysts-expect-equifax-inc-efx-will-post-quarterly-sales-of-824-58-million/1739110.html
Receive News & Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related companies with MarketBeat.com's FREE daily email newsletter.